Navigation Links
TRiUS Data Suggests That Testim® Significantly Improved Sexual Function in Hypogonadal Men
Date:11/3/2011

th increased total testosterone levels.

Significant improvement in sexual function from baseline scores was also seen in a subset of study participants concurrently using PDE5 inhibitors (for example, Viagra® and Cialis®) for erectile dysfunction (ED). Patients on PDE5 inhibitors had significantly lower baseline sexual function scores than other participants, but these scores improved after six and 12 months of TRT.  

"About 30 percent of ED patients treated with PDE5 inhibitors do not show improved sexual function," said Dr. James P. Tursi, Chief Medical Officer at Auxilium. "The results from TRiUS provide a valuable look at the potential real-life benefits of TRT for this challenging group of patients with the co-morbid conditions of ED and low testosterone."

"These study results suggest that TRT may be useful in treating sexual dysfunction in hypogonadal men with co-morbid ED," said Dr. Khera. "Men presenting with ED should be screened for hypogonadism and TRT should be considered as an additional therapy if their testosterone levels are below the normal range."

About TRiUS

The Testim Registry in the U.S. (TRiUS) is an observational study to evaluate the effectiveness and short and long term outcomes of testosterone replacement therapy by collecting readily available data from clinical practice settings.  Working with practicing physicians in the U.S., the registry, which is supported by Auxilium Pharmaceuticals, collects data from 849 hypogonadal men who have been prescribed Testim by their physician-investigator.

About Testim

Testim is a proprietary, clear topical gel containing 1% testosterone, the same type of hormone that is produced by the human body.  Testim is used to treat adult males who have low or no testosterone.  When applied once daily to the upper arms and shoulders, clinical studies have shown that Testim will restore and maintain testosterone levels.
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
2. Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
3. Trius to Present at the Stifel Nicolaus Healthcare Conference
4. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
5. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
6. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
7. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
8. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
9. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
10. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
11. Trius Doses First Patient in Antibacterial Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Sigma-Aldrich Corporation (NASDAQ: ... Technology company, today announced the opening of its ... state-of-the-art Cell Culture Technical Center in Singapore.  Located ... customized support to meet customer needs, leveraging the ... new Technical Center will significantly enhance our ability ...
(Date:4/17/2015)... , April 17, 2015 TWi Pharmaceuticals, ... subsidiary, TWi Pharmaceuticals USA , has ... the United States.  It has been in close contact ... and expects to have its own label specialty generic ... in the U.S. pharma market. According to ...
(Date:4/16/2015)... , April 16, 2015 Mindray ... developer, manufacturer, and marketer of medical devices worldwide, ... Securities and Exchange Commission an Annual Report on Form ... year ended December 31, 2014. An electronic version of ... on Mindray,s investor relations website at  http://ir.mindray.com  or  ...
Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
... 14, 2011 Reportlinker.com announces that a new ... Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic title=,The 2011 Prostatic ... Test Volume, Sales ... Acid Phosphatase Testing Market: US, Europe, Japan ...
... Nov. 14, 2011 Reportlinker.com announces that a ... catalogue: Smart Infusion Pumps ... is one of the most common therapeutic procedures ... to receive. Yet the lack of standardization among ...
Cached Medicine Technology:The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 2The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 3The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 4The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 5Smart Infusion Pumps 2Smart Infusion Pumps 3
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog post ... during Spring. , Spring can be a great ... make sure they compare the newest policies before deciding ... more about Spring car insurance offers by reading the ... are becoming more and more popular. Many insurance brokerage ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Review of ... hosting a ‘Strategies for Success’ program for cataract surgeons ... meeting in San Diego, where eye surgeon Jeffrey L. ... this invitation-only event. Dr. Martin is the Managing Partner ... of Ophthalmology chose Dr. Martin to lead this year’s ...
(Date:4/18/2015)... Patients who undergo radiation for a ... in life, but the disease is likely to differ ... to radiation. Surviving Mesothelioma has just posted the details ... here to read it now. , Scientists from ... 45 patients who had both a hematologic cancer (like ...
(Date:4/18/2015)... NY (PRWEB) April 18, 2015 On April ... Security Threat Report , which they say, “exposes a tactical ... many new malware variants were introduced in 2014 - almost ... for Zero Day threats to be identified and patched by ... is abundantly clear that doing business in a digital world ...
(Date:4/18/2015)... Canada (PRWEB) April 18, 2015 French ... emotions on food choices when he uttered, “Tell me ... you are.” Using food to cope with stress or ... by Queendom.com indicates otherwise. Data collected from ... genders fall victim to emotional eating, but for different ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6
... regimen popular in 1980s doesn,t really lengthen life , , ... only a minimal effect on survival in breast cancer ... pretty clearly established that [high-dose chemotherapy] is a false ... Division of Quantitative Sciences at the University of Texas ...
... is a three-day multidisciplinary meeting that will serve as ... the prevention, screening and treatment of gastrointestinal cancers. More ... years Symposium which will feature nearly 600 scientific abstracts. ... 27, 2008, WHERE:, Orlando World Center Marriott , 8701 ...
... at the Universities of Nottingham and Leicester are collaborating ... image and quantify the air spaces inside the lungs ... to a link between childhood disease and later degenerative ... the world which have access to this particular magnetic ...
... Boston, MAMichael F. Holick, PhD, MD, was recently awarded ... Society of Endocrinology and Metabolism (CSEM). Holick, an ... received the award for decades of pioneering work that ... wide variety of chronic health conditions. , ...
... at Henry Ford Hospital on the use of a drug ... and aggressive type of brain cancer, has yielded results that ... II study focused on patients with glioblastoma multiforme (GBM), whose ... revealed that more than a third who were treated with ...
... them from being attacked by the female immune system could ... the human body, according to new research published on 14 ... in the Journal of Biological Chemistry, analysed these markers which ... sperm are not dangerous pathogens, and therefore should not be ...
Cached Medicine News:Health News:High-Dose Chemo Provides Little Benefit to Breast Cancer Patients 2Health News:High-Dose Chemo Provides Little Benefit to Breast Cancer Patients 3Health News:New technique reveals insights into lung disease 2Health News:Boston University Medical Center researcher honored 2Health News:Drug study for brain cancer shows promising results 2Health News:Sperm's immune-protection properties could provide link to how cancers spread 2
... Tissue Anchor 3 mm is a resorbable repair ... using sutures. The resorbable repair device is implanted ... is used to attach soft tissue. The suture ... from glycolide and lactide colored with D&C violet ...
Sutureless Harpoon Tip...
... anchor is generally utilized when a surgeon would ... soft tissue, or seat the anchor below the ... 4.4mm anchor is the same as what comes ... a longer, calibrated shaft to easier gauge anchor ...
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
Medicine Products: